Results 61 to 70 of about 1,973,515 (250)
Examples of the evaluation of tumor infiltrating lymphocytes.
Examples of the evaluation of tumor infiltrating lymphocytes(TILs) in the present study. The mean percentage of the area occupied by TILs in 5 areas per section was reported as the density of TILs.
Hiroaki Tanaka (372008) +9 more
core +1 more source
Effect of combining thermal ablation and liposomal GM-CSF on periablational rim and untreated index tumor infiltration of tumor infiltrating lymphocytes.
S. Nahum Goldberg (222462) +13 more
core +1 more source
Anti‐PD‐1/PD‐L1 blockade has revolutionized cancer immunotherapy, but is ineffective against endocrine‐treated (i.e., Tamoxifen), relapsed ER+ breast cancer (BC) patients. This study provides insight into the sub‐optimal response of ER+BCs to anti‐PD‐1/PD‐L1 blockade – highlighting the induction of STING and the CEACAM1/TIM3 axis after chronic ...
Marvin Angelo E Aberin +20 more
wiley +1 more source
Tumor-infiltrating lymphocytes in triple negative breast cancer [PDF]
The aim of this retrospective study is to assess the prognostic value of tumor-infiltrating lymphocytes in triple negative breast carcinomas that lack both estrogen, progesterone receptors and Her2 amplification.
L. M. Zakhartseva, M. O. Yanovytska
core +1 more source
This study reveals that NF‐κB1‐driven TRAIP upregulation in ALD correlates with disease severity. Mechanistically, TRAIP directly binds β‐catenin via its CC domain and promotes its K48‐linked ubiquitination and degradation, which is independent of the GSK3β/β‐TrCP pathway.
Zhan Wu +13 more
wiley +1 more source
Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
Objective: Triple-negative-breast-cancer (TNBC) is a very heterogenous disease some of which are very aggressive and have poor prognosis. No targeted therapy is available.
Dulgar, Ozgecan +6 more
core +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
A multifunctional HA‐conjugated nanoplatform (HA‐PGMC) integrates CuO2, glucose oxidase, and mil‐100 to enable cascade catalytic ROS generation in tumor microenvironments. This self‐supplying ROS strategy induces immunogenic cell death, reprograms “cold” tumors into “hot” ones, and synergizes with PD‐L1 blockade, achieving potent chemodynamic ...
Man Lung Lee +6 more
wiley +1 more source
Phenotypic Analysis of Tumor-Infiltrating Lymphocytes in Hepatocellular Carcinoma
Background/Aims: Tumor may induce local immunosuppression and make the tumor-infiltrating lymphocytes (TILs) functionally inhibited and lose the ability to clonal proliferation and exert their cytotoxicity to tumor cells.
陳健弘;李宣書;黃冠棠;楊培銘;于位元;鄭光淳;李伯皇;鄭永銘;陳定信;許金川 +1 more
core
Additional file 1: Table S1. Completed and Published Trials with Tumor-infiltrating Lymphocytes in Patients with Melanoma.
Joost van den Berg (5817230) +3 more
core +1 more source

